Kroeger Christopher A. 4
4 · MapLight Therapeutics, Inc. · Filed Jul 17, 2026
Research Summary
AI-generated summary of this filing
MapLight (MPLT) CEO Christopher Kroeger Sells Shares
What Happened
- Christopher A. Kroeger, CEO of MapLight Therapeutics (MPLT), reported multiple open-market sales of company stock executed July 15–17, 2026. Over three days he disposed of a total 147,639 shares for aggregate proceeds of approximately $5,443,723.
- Daily breakdown:
- July 15: 61,778 shares sold (18,950 @ $36.00 = $682,200; 42,738 @ $36.99 = $1,580,879; 90 @ $37.54 = $3,379) — total ~$2,266,458.
- July 16: 69,082 shares sold (40,899 @ $36.46 = $1,491,178; 28,091 @ $37.26 = $1,046,671; 92 @ $37.96 = $3,492) — total ~$2,541,341.
- July 17: 16,779 shares sold (16,779 @ $37.90 = $635,924) — total ~$635,924.
- These were sales (code S). Some of the sales were mandatory "sell-to-cover" transactions to satisfy tax withholding on RSU vesting (see footnote F1); others were open-market disposals.
Key Details
- Transaction dates: July 15–17, 2026. Filing date: July 17, 2026 (appears timely under Form 4 rules).
- Total shares sold: 147,639; total proceeds: ~$5.44 million.
- Prices reported as weighted averages in several line items; reported price ranges in the filing:
- $35.5338–$36.5273 (F2)
- $36.53–$37.405 (F3)
- $35.9075–$36.9013 (F4)
- $36.9082–$37.89 (F5)
- $37.49–$37.925 (F6)
- Footnote F1: at least some shares were sold to cover statutory tax withholding for RSU vesting (sell-to-cover), not discretionary sales.
- Footnote F7: certain shares are held by the C&M Kroeger Nominee Trust; Kroeger is co-trustee with voting and dispositive power.
- Shares owned after the transactions are not provided in the summary here — see the full Form 4 for post-transaction holdings.
Context
- These transactions are sales (often routine or tax-related). The presence of a sell-to-cover footnote indicates at least part of the activity was tied to RSU vesting tax obligations rather than a discretionary signal about company prospects.
- No purchases, option exercises, or gifts are reported in this filing. For full allocation of which sales were discretionary vs. mandatory, or to see exact per-trade prices within the reported ranges, consult the detailed Form 4 or request the breakdown referenced in the filing.
Insider Transaction Report
Form 4
Kroeger Christopher A.
DirectorChief Executive Officer
Transactions
- Sale
Voting Common Stock
[F1][F2]2026-07-15$36.00/sh−18,950$682,200→ 1,375,144 total - Sale
Voting Common Stock
[F1][F3]2026-07-15$36.99/sh−42,738$1,580,879→ 1,332,406 total - Sale
Voting Common Stock
[F1]2026-07-15$37.54/sh−90$3,379→ 1,332,316 total - Sale
Voting Common Stock
[F1][F4]2026-07-16$36.46/sh−40,899$1,491,178→ 1,291,417 total - Sale
Voting Common Stock
[F1][F5]2026-07-16$37.26/sh−28,091$1,046,671→ 1,263,326 total - Sale
Voting Common Stock
[F1]2026-07-16$37.96/sh−92$3,492→ 1,263,234 total - Sale
Voting Common Stock
[F1][F6]2026-07-17$37.90/sh−16,779$635,924→ 1,246,455 total
Holdings
- 101,190(indirect: See footnote)
Voting Common Stock
[F7]
Footnotes (7)
- [F1]Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.5338 to $36.5273 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.53 to $37.405 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.9075 to $36.9013 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.9082 to $37.89 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.49 to $37.925 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]The shares are held by the C&M Kroeger Nominee Trust, of which the Reporting Person is co-trustee with his spouse and has voting and dispositive power.
Signature
/s/ Kristopher L. Hanson, Attorney-in-Fact|2026-07-17